FindMyKOL
Clinical trialNCT05693766RecruitingPhase 2Interventional

Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort

SponsorSonya ReidEnrollment64Invasive Mammary CarcinomaMetastatic Breast Cancer
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is an open-label, multicenter, two-arm Phase II clinical trial that will evaluate the impact of 2nd line chemotherapy (i.e. capecitabine) on survival in patients with non-Luminal A hormone receptor-positive (HR+) metastatic breast cancer (MBC)
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Alabama Birmingham

    Birmingham, Alabama, United States

    Nusrat Jahan
    Recruiting
  • Vanderbilt University/ingram Cancer Center

    Nashville, Tennessee, United States

    Sonya Reid, MD
    Recruiting
  • Ut Southwestern Medical Center

    Dallas, Texas, United States

    Heather McArthur, MD, PhD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Capecitabine →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Sept 2023
Primary completion
31 Aug 2027
Completion
31 Aug 2037
Last update posted
20 Jan 2026
Registered enrollment
64
Registry id
NCT05693766
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.